You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -1,043.5% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -24.2 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 229.6 | n/a |
Price / Book value | 6.6 |
Latest | Forecast | |
---|---|---|
Revenue | -26.8% | n/a |
PBT | 0.0% | n/a |
EPS | 0.0% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 0.20 | -0.53 | -5.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 0.46 | -0.72 | -8.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 0.34 | -3.64 | -26.00p | -23.7 | 0.0 | n/a | n/a | 0.0% |
4basebio enters neurofibromatosis collaboration with two universities Sharecast News | 10 Jun |
---|---|
Losses to continue as 4basebio focuses on commercialisation Sharecast News | 09 May |
4basebio inks development deal with Heqet Therapeutics Sharecast News | 27 Apr |
4basebio Plc - Director/PDMR Shareholding | 13-Jul-22 07:01 |
---|---|
4basebio Plc - Director/PDMR Shareholding | 16-Jun-22 15:29 |
4basebio Plc - Research Collaboration | 10-Jun-22 07:01 |
4basebio Plc - Result of AGM | 09-Jun-22 11:39 |